T. Kurz et al., 2 DIFFERENT MECHANISMS OF NORADRENALINE RELEASE DURING NORMOXIA AND SIMULATED ISCHEMIA IN HUMAN CARDIAC TISSUE, Journal of Molecular and Cellular Cardiology, 27(5), 1995, pp. 1161-1172
Species-related differences in the mechanisms of noradrenaline release
during normoxia and myocardial ischemia emphasize the need for studie
s on human hearts. Therefore, the mechanisms of noradrenaline release
were investigated during normoxia and energy depletion in incubated hu
man atrial tissue and compared to the release characteristics in normo
xic and ischemic rat heart. Potential differences of atrial versus Ven
tricular myocardium were assessed by comparing catecholamine release d
uring electrical stimulation and ischemia in isolated rat atrium with
release characteristics in the intact perfused heart. The overflow of
endogenous noradrenaline and its deaminated metabolite dihydroxyphenyl
ethyleneglycol (DOPEG) were determined by high pressure liquid chromat
ography and electrochemical detection. During normoxia noradrenaline r
elease was evoked by electrical field stimulation. Stimulation-induced
noradrenaline release depended on the extracellular calcium concentra
tion in both species and was almost completely suppressed under calciu
m-free conditions. The release was significantly inhibited by neuronal
(N-type) calcium channel blockers such as omega-conotoxin (100 nmol/l
) and cadmium chloride (100 mu mol/l), indicating a predominant role o
f N-type calcium channels in exocytotic noradrenaline release from sym
pathetic neurons in human and rat heart. Desipramine (100 nmol/l) enha
nced the overflow of noradrenaline evoked by electrical stimulation in
both species by blocking neuronal catecholamine uptake (uptake(1)). M
yocardial ischemia was caused by interruption of perfusion now in rat
heart and simulated by anoxic and glucose-free incubation in human and
rat atrial tissue. Ischemia- and anoxia-induced noradrenaline release
in rat heart and human atrial tissue was unaffected by varying extrac
ellular calcium concentrations and occurred even after omission of cal
cium and addition of EGTA (mmol/l). In both species neither omega-cono
toxin (100 nmol/l) nor cadmium chloride (100/mu mol/l) affected ischem
ia-induced noradrenaline overflow in both rat heart and atrium as well
as in human atrium. In human and rat atrial tissue, blockade of energ
y metabolism in the presence of oxygen (cyanide model) resulted in a d
esipramine-sensitive release of noradrenaline, which was accompanied b
y DOPEG overflow, indicating increased axoplasmic noradrenaline concen
tration, The data imply a dual mechanism of noradrenaline release in t
he human heart. During normoxia noradrenaline release is modulated by
neuronal calcium influx indicating exocytotic release. Ischemia-induce
d noradrenaline release, however, is independent of calcium and inhibi
ted by uptake(1) blockade suggesting nonexocytotic release mechanism.
The characteristics of noradrenaline release in human atrial tissue pr
ovide evidence for carrier-mediated release of noradrenaline from symp
athetic neurons operative in the ischemic human myocardium.